Dietary Supplements

Browse Dietary Supplements Content

Press Releases and Statements

CHPA released the following statement in response to new research published in Clinical Toxicology. The study found nine illegal stimulants, including deterenol, in fraudulently marketed sports and weight loss supplements.

Mar 23, 2021

Press Releases and Statements

CHPA congratulates Xavier Becerra upon his confirmation by the U.S. Senate as Secretary of the Department of Health & Human Services (HHS).

Mar 18, 2021

Press Releases and Statements

As in past years, the 2021 summit will feature updates and insights from top FDA officials, including the Office of Dietary Supplement Programs, and industry experts, with a focus on dietary supplement regulatory compliance.

Mar 17, 2021

Press Releases and Statements

CHPA welcomes Church & Dwight, Co., Inc., Bridges Consumer Healthcare, and Rhinomed Inc. as its newest manufacturer members of the association.

Feb 22, 2021

Press Releases and Statements

CHPA issued the following statement regarding the changes in leadership at the FDA Office of Dietary Supplement Programs.

Feb 19, 2021

Press Releases and Statements

CHPA, along with a wide coalition of organizations, co-signed a joint press release in support of the re-introduction of this bipartisan CBD bill.

Feb 4, 2021

Article

For its annual year-in-review series, Chain Drug Review featured CHPA's President & CEO, Scott Melville, who offered industry insights from last year and thoughts on the outlook for 2021.

Jan 7, 2021

Filter Results